Gianluca Franceschini: The Difference in Breast Cancer is Made by the Team
Gianluca Franceschini, Director of the Research and Training Center on Integrated Therapies in Breast Neoplasms, Full Professor of General Surgery and Director of the Master’s Program in Integrated Therapies for Female Oncological Pathologies at Catholic University of the Sacred Heart, shared a post on LinkedIn:
“The difference, in breast cancer, is made by the Team!
I had the pleasure of participating in the program ‘Il Confronto‘ on Rai 2, conducted by Monica Setta, in an episode dedicated to current health, economic and social issues together with Lando Maria Sileoni (Secretary General of the Autonomous Federation of Italian Banks), Dario Lo Bosco (General Manager of Italferr) and Corrado Chiominto (Editor-in-Chief of the economic and financial editorial staff of the Ansa Agency).
During my speech, I wanted to draw attention to a fundamental issue for women’s health: the importance of being treated within a Breast Unit.
The scientific evidence is now very clear: women treated in multidisciplinary centers dedicated to breast cancer have greater survival and better quality of life.
The real difference today is not the individual doctor, but the strength of the team!
Continuing to inform and raise awareness on this issue is essential, because the quality of the organization of care can make a difference in people’s lives.
Here is the video with the full interview.”
Proceed to the video attached to the post.
Other posts featuring Gianluca Franceschini on Hemostasis Today.
-
Nov 18, 2026, 15:11Vansh Yaduvanshi: Why Compatible Blood Groups Do Not Always Mean Compatible Blood
-
Nov 18, 2026, 14:49Estetrol-Based Contraception in PCOS and Its Effects on Coagulation – RPTH Journal
-
Nov 18, 2026, 14:41Factor V Deficiency: Diagnostic Challenges and the Role of Combined Factor V and VIII Deficiency
-
Nov 18, 2026, 14:29Maxime Dely: When Patient Encounters Become Life Lessons
-
Nov 18, 2026, 14:23Basanta Khatiwada: Advancing Haematology Through Research and Innovation at HAEMATOCON 2026
-
Nov 18, 2026, 14:13Alvin Katumba: Sickle Cell Disease Research Recognised With a 2026 ASH Abstract Achievement Award
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: The Ecological Transition in Thrombosis and Haemostasis